A drugmaker and its CEO, who previously defended Martin Shkreli for raising drug prices, have agreed to settle allegations of underpaying Medicaid rebates. Telemedicine solutions are revolutionizing rural healthcare, addressing physician shortages and providing access to care. Eli Lilly will pay $200 million for Beam's share of drugs from gene-editing firm Verve. Medicare officials are moving forward with a plan to claw back money from certain hospitals to remedy overpayments related to the 340B program. A key Senate panel will consider policies to regulate pharmacy middlemen and reduce medication costs. Medicare has implemented payment cuts for doctors and hospitals. The US government is allowing Medicare to negotiate drug prices to address the high costs faced by Americans.
For too long, Americans have paid more for prescription drugs than any major economy. Now, instead of paying whatever the drug company wants to charge, Medicare can negotiate prices. We’re making progress and helping folks like Judith get a little more breathing room. https://t.co/nwa8ZCknmv
Medicare cuts doctor and hospital payments https://t.co/UtqeiV9gwD
Medicare administrators served doctors and hospitals a pair of big payment cuts late Thursday. https://t.co/J5ITpT5OGQ
A key Senate panel announced it will consider policies to regulate pharmacy middlemen and ensure patients pay less for medications. https://t.co/AvsM4zvVlh
Drugmakers are up in arms over a new program allowing Medicare to negotiate prices on some drugs. The real scandal, of course, is the absurd prices the companies set for these drugs’ sale in the United States, when they are sold for so much less elsewhere. https://t.co/ffeAuxZYIA
Medicare officials are moving forward with a plan to claw back money from certain hospitals to try to remedy overpayments related to the 340B program. https://t.co/qH4BXvx5hm
California healthcare provider's move shows pitfalls of Medicare Advantage https://t.co/fPa6tajT1k https://t.co/SIEOdJHIbC
Getting prescription drugs online is so easy. Are regulators paying attention? https://t.co/QEmAUjpuHA
Eli Lilly to pay $200 million for Beam’s share of drugs from gene-editing firm Verve. https://t.co/mufuqD7r5M
Physician shortages mean that people in rural areas must routinely drive hours to see their doctors or simply go without care. Some doctors see telehealth as the solution. https://t.co/qF8JmhrB49
Amid Regulatory Gaps, Telehealth Prescribers Flourish https://t.co/NIg96B2Zhw
NEW on i.t ‼️ Telemedicine Solutions Revolutionize Rural Healthcare https://t.co/9Tf21MSdey
A drugmaker and its chief executive — who once defended Martin Shkreli for raising drug prices — agreed to settle allegations of purposely underpaying Medicaid rebates. https://t.co/k0inql4lIB